SEC Form 5
FORM 5 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
Form 3 Holdings Reported. | |||||||||||||||||
Form 4 Transactions Reported. |
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol AMERICAN BIO MEDICA CORP [ abmc ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year) 12/31/2019 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||||||
Amount | (A) or (D) | Price | |||||||||||||
Common Shares(1) | 10/10/2019 | A | 37,398 | A | $0.09 | 37,398 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
(A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | |||||||||
Non-Statutory Stock Option(1) | $0.12 | 06/19/2015 | J | 20,000 | 06/19/2016 | 06/19/2025(3) | Common Shares | 20,000 | $0.115 | 20,000 | D | |||
Non-Statutory Stock Option(1) | $0.15 | 06/24/2016 | J | 20,000 | 06/24/2017 | 06/24/2026(3) | Common Shares | 20,000 | $0.15 | 20,000 | D | |||
Non-Statutory Stock Option(1) | $0.13 | 06/15/2017 | J | 20,000 | 06/15/2018 | 06/15/2027(3) | Common Shares | 20,000 | $0.13 | 20,000 | D | |||
Non-Statutory Stock Option(1) | $0.1 | 06/21/2018 | J | 20,000 | 06/21/2019 | 06/21/2028(3) | Common Shares | 20,000 | $0.1 | 20,000 | D | |||
Non-Statutory Stock Option(1) | $0.07 | 06/20/2019 | J | 20,000 | 06/20/2020(2) | 06/20/2029(3) | Common Shares | 20,000 | $0.07 | 20,000 | D |
Explanation of Responses: |
1. Previously reported on Form 4 |
2. Generous resigned from the Board of Directors effective January 7, 2020. Although the options were not fully vested as of the date of the resignation, the options will continue to vest as if such resignation did not occur, provided that Generous does not engage in any activity detrimental to the Company's interest. |
3. The Board of Directors does reserve the right to termination stock options with respect to any and all unexercised shares if Generous engages in any activity detrimental to the Company's interest. |
Remarks: |
42,600 common shares previously indicated as indirectly owned by Generous ("common shares held FBO children") are no longer indirectly owned by Generous due to the age of such children. |
Diane Generous | 01/13/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |